Calculus launches £10m VCT fundraise

Over-allotment of up to £10m

clock • 1 min read

Calculus has launched a £10m fundraise offer for its VCT, set to close on 30 August 2024.

The offer is accompanied by an over-allotment facility of up to £10m, bringing the total fundraise to a potential £20m. Calculus VCT offers investors a portfolio targeting sectors including technology, healthcare and entertainment, and currently holds Oxford BioTherapeutics, Optalix and Rotageek as part of the fund. Calculus capitalises on lifted EIS sunset clause with new fund The offer has a minimum investment threshold of £5,000, and the managers hope to attract "seasoned and new investors". John Glencross, chief executive and co-founder of Calculus Capital, said: "Our journe...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on VCTs/EIS

Defaqto unveils new ratings for AIM and unlisted BR services

Defaqto unveils new ratings for AIM and unlisted BR services

Following MICAP acquisition

Sahar Nazir
clock 22 January 2024 • 2 min read
Calculus launches next EIS offering with tech and healthcare focus

Calculus launches next EIS offering with tech and healthcare focus

£2 tax free for each £1 invested

Hope Coumbe
clock 18 January 2024 • 1 min read
Venture Capital Trust Association names chair

Venture Capital Trust Association names chair

Chris Lewis joins

Cristian Angeloni
clock 08 January 2024 • 1 min read
Trustpilot